DPT vaccination rate in children ages 1 to 5 years old and associated factors in K’bang District, Gia Lai Province, Viet Nam in 2015 | Zendy

P.V. Doanh | Zendy; D. Pham T | Zendy; H. Do T H | Zendy; N. Leisha | Zendy; KM Klein | Zendy; L. Vu N | Zendy; V. Nguyen Q | Zendy; Oanh Dang | Zendy; T. Chu | Zendy; Van Dinh Tran | Zendy; T. Pham N | Zendy; Hien Thi Nguyen | Zendy; H. Nguyen TT | Zendy; T. Hoang N | Zendy; T. Mounts | Zendy

Open Access

DPT vaccination rate in children ages 1 to 5 years old and associated factors in K’bang District, Gia Lai Province, Viet Nam in 2015

Author(s) -

P.V. Doanh,

D. Pham T,

H. Do T H,

N. Leisha,

KM Klein,

L. Vu N,

V. Nguyen Q,

Oanh Dang,

T. Chu,

Van Dinh Tran,

T. Pham N,

Hien Thi Nguyen,

H. Nguyen TT,

T. Hoang N,

T. Mounts

Publication year - 2016

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2016.02.483

Subject(s) - vaccination , medicine , demography , logistic regression , immunization , ethnic group , cross sectional study , cluster (spacecraft) , pediatrics , environmental health , immunology , sociology , pathology , antigen , anthropology , computer science , programming language

negative subjects (p<0.0001). 97.8% of the JEV positive and 92.5% of inconclusive samples had detectable titres against all four dengue serotypes, compared with 71.0% of the JEV negative samples. For every monotypic dengue serotype, the GMT was highest in JEV positive subjects, followed by those with an inconclusive JEV result, and lowest in the JEV negative group. Conclusion: While limited by a lack of PRNT data from dengue IgG negative subjects, these results suggest that JEV IgG ELISA test results in dengue-endemic areas should be viewed with caution. More specific laboratory methods, such as JEV PRNT, should be employed where available.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research